CAS No. 203248-77-5

Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl-

Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl-

Identification

Catalog number1957063
Chemical nameButanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl-
CAS RN 203248-77-5
Molecular formulaC13H19NO5S

Structure

203248-77-5 structure

Classification

About Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl-

Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl- is a chemical compound registered under CAS number 203248-77-5, with the molecular formula C13H19NO5S and a molecular weight of about 301.36 g/mol. CKSOne supplies Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl]methyl]-3-methyl- for laboratory research and bulk production; product code 1957063. Send an inquiry for purity, packaging, price and lead time.

CAS Number
203248-77-5
Molecular Formula
C13H19NO5S
Molecular Weight
301.36 g/mol
Related Keywords
sulfonyl
butanamide
methoxyphenyl
  • 2,6,8-Decatrienoic acid,10-[(2R,3S,6R,8R,9S)-8-[(1E,3E)-4-carboxy-3-methyl-1,3-butadienyl]-3,9-dimethyl-1,7-dioxaspiro[5.5]undec-2-yl]-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4,8-dimethyl-, (2E,4S,5S,6E,8E)-
  • 1,4-Benzodioxin-6-acetic acid, alpha-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-, (R)
  • 2-({2,5-dioxo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-3-yl}sulfanyl)-N-1,3-thiazol-2-ylbenzamide
  • 1,2-DIHYDROPERILLALDEHYDE
  • Benzeneacetic acid, alpha-[[(1,1-dimethylethoxy)carbonyl]amino]-4-methoxy-3-methyl-, (R)
  • Benzoic acid, 4-[[4-(3-methoxyphenyl)-6-oxo-2-morpholinyl]methoxy]-
    61974-54-7
  • Acetamide,2-ethoxy-N-[4-(4-methoxy-3-methylphenyl)cyclohexyl]-N-(phenylmethyl)-,cis-
  • Benzoic acid, 4-[(1E)-[4-hydroxy-3-(pentadecadienyl)phenyl]azo]-
  • 2-(6,11-dihydrobenzo[b][1,4]benzodiazepin-5-yl)ethyl-dimethylazanium;(z)-4-hydroxy-4-oxobut-2-enoate
  • Benzoic acid, 4-[(1E)-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)azo]-,ethyl ester
  • 2,2',2''-nitrilotrisethyl tris(dihydrogen phosphate), compound with morpholine
  • 1,2,3,5-Thiatriazole,4-butyl-2,5-dihydro-2-(3-methylphenyl)-5-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, 1-oxide
    175473-69-5
  • Benzene, 1-bromo-4-(1,1-dimethylethyl)-2-nitro-
  • 3-(2,3-dichlorophenyl)-2-methylquinazolin-4(3H)-one
  • 1(2H)-Naphthalenone, 3,4-dihydro-7-(hydroxyphenylmethyl)-
  • heptadec-16-ene-1,2,4-triol
  • 4-(2-OXO-OXAZOLIDIN-3-YL)-BENZOIC ACID
  • 5-(4-hydroxy-3-iodo-5-methoxyphenyl)-8,8-dimethyl-2-(prop-2-en-1-ylsulfanyl)-5,8,9,10-tetrahydropyrimido[4,5-b]quinoline-4,6(1H,7H)-dione
    7062-41-1
  • Benzamide,3-[[3-(2,6-dichlorophenyl)-1-methyl-1H-pyrimido[4,5-e][1,3,4]oxadiazin-7-yl]amino]-N-methyl-
  • Benzenemethanamine, 2-amino-N-phenyl-
  • Benzamide,3-[2-[(3-chlorobenzoyl)amino]-3-cyano-6-(2-hydroxyphenyl)-4-pyridinyl]-N-3-pyrrolidinyl-, 2,2,2-trifluoroacetate (1:2)
  • 1,3-Benzodioxole, 5-(4-iodophenoxy)-
  • Benzoic acid, 4-[(3-carboxy-4-hydroxyphenyl)amino]-3,5-dinitro-
    292852-76-7
  • Benzoic acid, 4-[(3-furanylmethyl)amino]-
  • 1,2,3,5-Thiatriazole,4-butyl-2,5-dihydro-2-phenyl-5-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, 1-oxide
  • Phenol, 2-(aminomethyl)-4,6-diiodo-
  • STELLADELIN D
  • ({4-[bis(2-chloroethyl)amino]phenyl}sulfanyl)acetic acid
  • Cyclohexanecarbonitrile, 4-[2-(4-pentylphenyl)ethyl]-, trans-
    83799-89-7
  • Benzoic acid, 4-methyl-, 5-(aminocarbonyl)-1H-imidazol-4-yl ester
  • Piperazine, 1-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-
  • Piperazine,1-[[(1R,3S)-1-(1-hydroxy-1-methylethyl)-3-[[(4R)-tetrahydro-3-methyl-2H-pyran-4-yl]amino]cyclopentyl]carbonyl]-4-[4-(trifluoromethyl)-2-pyrimidinyl]-
  • cyclohexyl 4-({[5-(2-chloro-4-nitrophenyl)furan-2-yl]carbonyl}amino)benzoate
  • 2,4(1H,3H)-Quinazolinedione,7-chloro-3-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-1-ethyl-
  • Cyclopentanecarboxylic acid,3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-[(3R)-tetrahydro-3-furanyl]-,(1S,3R)-
    872592-96-6